NCT06224933 Augmented Reality For MRI-Guided Interventions
| NCT ID | NCT06224933 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's National Research Institute |
| Condition | Infections |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-02-06 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2024-02-06 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine feasibility and safety of using an augmented reality system in patients undergoing MRI-Guided needle procedures.
Eligibility Criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, ages 3 to 21 * Patient referred to Interventional Radiology for image-guided needle injection, aspiration, or biopsy. Exclusion Criteria: * Patients who are unable to give informed consent themselves or through their parents. * Patients under 3 years of age * Patients over 300 pounds. * Patients who are claustrophobic and unable to tolerate MRI-guided procedure. * Contraindications to MRI such as MR-unsafe implants.
Contact & Investigator
Karun Sharma, MD, PhD
PRINCIPAL INVESTIGATOR
Children's National Research Institute
Frequently Asked Questions
Who can join the NCT06224933 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 21 Years, studying Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06224933 currently recruiting?
Yes, NCT06224933 is actively recruiting participants. Contact the research team at eleibold@childrensnational.org for enrollment information.
Where is the NCT06224933 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT06224933 clinical trial?
NCT06224933 is sponsored by Children's National Research Institute. The principal investigator is Karun Sharma, MD, PhD at Children's National Research Institute. The trial plans to enroll 25 participants.